PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatocellular carcinoma |
| Phenotype | C0028754|obesity |
| Sentences | 7 |
| PubMedID- 24223741 | Purpose: recent studies have revealed that branched-chain amino acids (bcaa) reduce the development of hepatocellular carcinoma (hcc) in patients with obesity and hepatitis c virus infection by improving insulin resistance (ir). |
| PubMedID- 22287480 | Background and objectives: adipokines may explain the newly established association of obesity with hepatocellular carcinoma (hcc). |
| PubMedID- 20723213 | Background: numerous epidemiological studies have documented that obesity is associated with hepatocellular carcinoma (hcc). |
| PubMedID- 26404865 | Sex and ethnic differences in the association of obesity with risk of hepatocellular carcinoma. |
| PubMedID- 25816330 | We have recently reported a novel rodent model of nash using melanocortin 4 receptor-deficient (mc4r-ko) mice, which exhibit the sequence of events that comprise hepatic steatosis, liver fibrosis, and hepatocellular carcinoma with obesity-related phenotypes. |
| PubMedID- 25117675 | Non-alcoholic steatohepatitis (nash) has emerged as a common cause of chronic liver disease and virus-independent hepatocellular carcinoma (hcc) in patients with obesity, diabetes, and metabolic syndrome. |
| PubMedID- 25864208 | obesity as a cause of hepatocellular carcinoma. |
Page: 1